ConductScience.org, home

Paper35196993

The changing pattern of bacterial and fungal respiratory isolates in patients with and without COVID-19 admitted to intensive care unit.

Zuglian G and 6 others. BMC Infect Dis, 2022. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. The changing pattern of bacterial and fungal respiratory isolates in patients with and without COVID-19 admitted to intensive care unit. Papers, record 35196993. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35196993

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The changing pattern of bacterial and fungal respiratory isolates in patients with and without COVID-19 admitted to intensive care unit.
PubMed
Journal
BMC Infect Dis
PubMed
Year
2022
PubMed
Publication types
Journal Article, Observational Study
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.72
iCite
Revised in PubMed
2022-02-28
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zuglian GGianluca
2Ripamonti DDiego
3Tebaldi AAlessandra
4Cuntrò MMarina
5Riva IIvano
6Farina CClaudio
7Rizzi MMarco

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
COVID-19Major topic
Anti-Bacterial Agents
Bacteria
Drug Resistance, Bacterial
Hospitalization
Humans
Intensive Care Units
Microbial Sensitivity Tests
Pandemics
Retrospective Studies
SARS-CoV-2

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133339536Corticosteroid therapy in critically ill patients with COVID-19: a multicenter, retrospective study.Crit Care2020https://conductscience.org/library/papers/33339536PubMed
233418017Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis.Clin Microbiol Infect2021https://conductscience.org/library/papers/33418017PubMed
333573070Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic.Antibiotics (Basel)2021https://conductscience.org/library/papers/33573070PubMed
434652416Pressure on the Health-Care System and Intensive Care Utilization During the COVID-19 Outbreak in the Lombardy Region of Italy: A Retrospective Observational Study in 43,538 Hospitalized Patients.Am J Epidemiol2022https://conductscience.org/library/papers/34652416PubMed
511337221Antibiotic selective pressure and development of bacterial resistance.Int J Antimicrob Agents2001https://conductscience.org/library/papers/11337221PubMed
634809698The effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: a nationwide surveillance study.Crit Care2021https://conductscience.org/library/papers/34809698PubMed
724614243Aetiology of hospital-acquired pneumonia and trends in antimicrobial resistance.Curr Opin Pulm Med2014https://conductscience.org/library/papers/24614243PubMed
833546093Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study.J Clin Med2021https://conductscience.org/library/papers/33546093PubMed
932835331Low rate of bacterial co-infection in patients with COVID-19.Lancet Microbe2020https://conductscience.org/library/papers/32835331PubMed
1033681246Bergamo and Covid-19: How the Dark Can Turn to Light.Front Med (Lausanne)2021https://conductscience.org/library/papers/33681246PubMed
1132878619COVID-19 length of hospital stay: a systematic review and data synthesis.BMC Med2020https://conductscience.org/library/papers/32878619PubMed
1233666657Outcomes and Mortality Among Adults Hospitalized With COVID-19 at US Medical Centers.JAMA Netw Open2021https://conductscience.org/library/papers/33666657PubMed
1333352303Decreased prevalence rate of respiratory pathogens in hospitalized patients during the COVID-19 pandemic: possible role for public health containment measures?Clin Microbiol Infect2021https://conductscience.org/library/papers/33352303PubMed
1421793988Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.Clin Microbiol Infect2012https://conductscience.org/library/papers/21793988PubMed
1531986264Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet2020https://conductscience.org/library/papers/31986264PubMed
1615190030Antibiotic usage in intensive care units: a pharmaco-epidemiological multicentre study.J Antimicrob Chemother2004https://conductscience.org/library/papers/15190030PubMed
1733388794Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study.Intensive Care Med2021https://conductscience.org/library/papers/33388794PubMed
1832567404Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2.Expert Rev Respir Med2020https://conductscience.org/library/papers/32567404PubMed
1927865895Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.J Infect2017https://conductscience.org/library/papers/27865895PubMed

Download CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41320199COVID-19 impact on AMR: a rapid scoping review, equity analysis and evidence gap map study.BMJ Glob Health2025https://conductscience.org/library/papers/41320199PubMed
41045404Impact of COVID-19 on the prevalence of multi-drug-resistant bacteria: a literature review and meta-analysis.Antonie Van Leeuwenhoek2025https://conductscience.org/library/papers/41045404PubMed
40304474Changing patterns and biological features of community-acquired Clostridioides difficile infection in Southwest China: 7 years of surveillance data.Microbiol Spectr2025https://conductscience.org/library/papers/40304474PubMed
38099348Impact of the COVID-19 pandemic on prevalence of highly resistant microorganisms in hospitalised patients in the Netherlands, March 2020 to August 2022.Euro Surveill2023https://conductscience.org/library/papers/38099348PubMed
37760760ICU-Acquired Colonization and Infection Related to Multidrug-Resistant Bacteria in COVID-19 Patients: A Narrative Review.Antibiotics (Basel)2023https://conductscience.org/library/papers/37760760PubMed
37508204Risk Factors Associated with the Development of Hospital-Acquired Infections in Hospitalized Patients with Severe COVID-19.Antibiotics (Basel)2023https://conductscience.org/library/papers/37508204PubMed
37184033Incidence and risk factors for clinically confirmed secondary bacterial infections in patients hospitalized for coronavirus disease 2019 (COVID-19).Infect Control Hosp Epidemiol2023https://conductscience.org/library/papers/37184033PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35196993

GET https://conductscience.org/api/papers/v1/35196993/authors